
GEHC Stock Forecast & Price Target
GEHC Analyst Ratings
Bulls say
GE HealthCare Techs is positioned for long-term success with its diverse portfolio, strategic investments in AI and digital solutions, and strong leadership. Their recent acquisition of Intelerad is expected to drive profits and they have set a goal of 60% recurring revenues to ensure stability and growth. While they face competition and sustainability risks, their focus on responsible practices and ability to innovate new products will help mitigate these challenges.
Bears say
GE HealthCare Techs is projected to experience significant sales growth in late 2026 and beyond, driven by competition in the market for their MRI systems and investments in new products and M&A. However, they face intense competition from established companies and potential challenges such as trade wars and inflation that could affect their performance. Additionally, while their use of AI technology and focus on sustainability and human capital are positives, their expansion into the theranostics field and implementation of AI for maternal and neonatal care may face regulatory hurdles.
This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
GEHC Analyst Forecast & Price Prediction
Start investing in GEHC
Order type
Buy in
Order amount
Est. shares
0 shares